Covered recipient · General Payments record
JAMES G CHUN
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2019–2025
$8,804.03
- Reported across 108 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.80 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BAXTER HEALTHCARE | $175.10 | 10 |
| PFIZER INC. | $23.90 | 1 |
| Esperion Therapeutics, Inc. | $23.72 | 1 |
| Abbott Laboratories | $23.44 | 1 |
| Octapharma USA, Inc. | $18.19 | 1 |
| CORDIS US CORP. | $17.46 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.44 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241057072 | CMS |
| Baxter Healthcare | $29.59 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533670 | CMS |
| Baxter Healthcare | $21.56 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533672 | CMS |
| Baxter Healthcare | $14.47 | 05/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533674 | CMS |
| Baxter Healthcare | $9.93 | 06/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533676 | CMS |
| Baxter Healthcare | $21.28 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533680 | CMS |
| Baxter Healthcare | $21.48 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533682 | CMS |
| Baxter Healthcare | $13.08 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533684 | CMS |
| Baxter Healthcare | $11.52 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533678 | CMS |
| Baxter Healthcare | $22.97 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533686 | CMS |
| Baxter Healthcare | $9.22 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181533688 | CMS |
| Boston Scientific Corporation | $16.99 | 11/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181172070 | CMS |
| CORDIS US CORP. | $17.46 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237401594 | CMS |
| Esperion Therapeutics, Inc. | $23.72 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243955282 | CMS |
| Octapharma USA, Inc. | $18.19 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245076215 | CMS |
| PFIZER INC. | $23.90 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231297632 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.